Marker Therapeutics (MRKR) FCF Margin (2016 - 2025)
Marker Therapeutics (MRKR) posted quarterly FCF Margin of 172.2% for Q4 2025, up 3667.0% year-over-year from 4.57% in Q4 2024, and up 22.4% quarter-over-quarter from 221.9% in Q3 2025.
Marker Therapeutics (MRKR) FCF Margin (2016 - 2025) Analysis & Trends
Marker Therapeutics (MRKR) has reported FCF Margin for 9 consecutive years, with 172.2% the latest figure, recorded in Q4 2025.
- In Q4 2025, FCF Margin rose 3667.0% year-over-year to 172.2%; the TTM figure through Dec 2025 stood at 338.74% (down 19174.0% YoY), while the FY2025 annual figure was 338.74%, down 17321.0% from the prior year.
- FCF Margin advanced to 172.2% in Q4 2025 per MRKR's latest filing, from 221.9% in the prior quarter.
- Across five years, FCF Margin topped out at 254.66% in Q2 2023 and bottomed at 2679.73% in Q3 2023.
- Historically, FCF Margin has averaged 519.18% across 4 years, with a median of 221.9% in 2025.
- Annual changes were most pronounced in 2023 — FCF Margin sank 223401 bps — and 2024, when it jumped 274190 bps.
- Marker Therapeutics' FCF Margin stood at 537.25% in 2022, then plunged by 399 bps to 2679.73% in 2023, then soared by 92 bps to 208.86% in 2024, then climbed by 18 bps to 172.2% in 2025.
- Business Quant data shows MRKR's FCF Margin at 172.2% in Q4 2025, 221.9% in Q3 2025, and 218.11% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 22.62% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -22.35% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 70.82% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 41.07% |
| 10 | Marker Therapeutics | 23.95 Mn | 12.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -172.20% |
| Sep 30, 2025 | -221.90% |
| Jun 30, 2025 | -218.11% |
| Mar 31, 2025 | -1,575.39% |
| Dec 31, 2024 | -208.86% |
| Sep 30, 2024 | 62.17% |
| Jun 30, 2024 | -178.38% |
| Mar 31, 2024 | -308.43% |
| Sep 30, 2023 | -2,679.73% |
| Jun 30, 2023 | 254.66% |
| Mar 31, 2023 | -241.21% |
| Dec 31, 2022 | -537.25% |
| Sep 30, 2022 | -445.71% |
| Jun 30, 2022 | 191.99% |
| Mar 31, 2022 | -1,509.31% |
| Dec 31, 2020 | -14,419.92% |
| Jun 30, 2020 | -1,463.56% |
| Dec 31, 2019 | -2,280.43% |
| Jun 30, 2018 | -1,164.70% |
| Sep 30, 2017 | -1,106.36% |